Johnson & Johnson PE Ratio 2006-2021 | JNJ

Current and historical p/e ratio for Johnson & Johnson (JNJ) from 2006 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Johnson & Johnson PE ratio as of October 22, 2021 is 17.18.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Johnson & Johnson PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2021-10-22 163.72 30.77
2021-09-30 161.50 $5.32 30.36
2021-06-30 163.76 $6.65 24.63
2021-03-31 162.37 $5.66 28.69
2020-12-31 154.52 $5.51 28.04
2020-09-30 145.15 $6.36 22.82
2020-06-30 136.20 $6.84 19.91
2020-03-31 126.12 $7.56 16.68
2019-12-31 139.39 $6.78 20.56
2019-09-30 122.78 $6.40 19.18
2019-06-30 132.18 $6.03 21.92
2019-03-31 131.76 $5.40 24.40
2018-12-31 120.84 $5.61 21.54
2018-09-30 128.56 $0.50 257.12
2018-06-30 112.15 $0.43 260.82
2018-03-31 117.58 $0.38 309.41
2017-12-31 127.38 $0.39 326.62
2017-09-30 117.81 $5.76 20.45
2017-06-30 119.12 $5.92 20.12
2017-03-31 111.41 $5.95 18.73
2016-12-31 102.39 $5.88 17.41
2016-09-30 104.26 $5.65 18.45
2016-06-30 106.35 $5.32 19.99
2016-03-31 94.20 $5.50 17.13
2015-12-31 88.79 $5.49 16.17
2015-09-30 80.10 $5.23 15.32
2015-06-30 82.98 $5.69 14.58
2015-03-31 85.03 $5.59 15.21
2014-12-31 87.77 $5.70 15.40
2014-09-30 88.89 $6.04 14.72
2014-06-30 86.66 $5.42 15.99
2014-03-31 80.81 $5.24 15.42
2013-12-31 74.80 $4.82 15.52
2013-09-30 70.31 $4.50 15.63
2013-06-30 69.13 $4.51 15.33
2013-03-31 65.15 $3.68 17.70
2012-12-31 55.57 $3.87 14.36
2012-09-30 54.15 $3.04 17.81
2012-06-30 52.61 $3.14 16.76
2012-03-31 50.88 $3.64 13.98
2011-12-31 50.14 $3.48 14.41
2011-09-30 48.25 $4.10 11.77
2011-06-30 49.95 $4.18 11.95
2011-03-31 44.10 $4.41 10.00
2010-12-31 45.63 $4.78 9.55
2010-09-30 45.32 $4.87 9.31
2010-06-30 42.79 $4.84 8.84
2010-03-31 46.81 $4.76 9.83
2009-12-31 45.89 $4.40 10.43
2009-09-30 43.05 $4.58 9.40
2009-06-30 39.84 $4.55 8.76
2009-03-31 36.56 $4.57 8.00
2008-12-31 41.24 $4.57 9.02
2008-09-30 47.38 $4.42 10.72
2008-06-30 43.72 $4.13 10.59
2008-03-31 43.78 $4.01 10.92
2007-12-31 44.72 $3.63 12.32
2007-09-30 43.78 $3.55 12.33
2007-06-30 40.78 $3.61 11.30
2007-03-31 39.62 $3.51 11.29
2006-12-31 43.16 $3.73 11.57
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $430.990B $82.584B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Novo Nordisk (NVO) Denmark $249.632B 34.64
Pfizer (PFE) United States $241.985B 13.75
Eli Lilly (LLY) United States $233.762B 30.35
Merck (MRK) United States $205.421B 14.06
AbbVie (ABBV) United States $192.870B 9.24
Novartis AG (NVS) Switzerland $189.944B 14.11
GlaxoSmithKline (GSK) United Kingdom $107.085B 13.44